Phillip A Sharp is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 121,174 shares of VIR, which is worth approximately $912,440. The most recent transaction as insider was on May 22, 2023, when has been sold 6,027 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
0% 3M change
0% 12M change
Total Value Held $912,440

PHILLIP A SHARP Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 22 2023
BUY
Grant, award, or other acquisition
-
6,027 Added 4.74%
121,174 Common Stock
May 23 2022
BUY
Grant, award, or other acquisition
-
6,405 Added 5.27%
115,147 Common Stock
May 21 2021
BUY
Grant, award, or other acquisition
-
3,374 Added 3.01%
108,742 Common Stock

Also insider at

ALNY
ALNYLAM PHARMACEUTICALS, INC. Healthcare
SYRS
Syros Pharmaceuticals, Inc. Healthcare
PAS

Phillip A Sharp

Director
Cambridge, MA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR